To direct the Secretary of Health and Human Services, in consultation with the United States Trade Representative and other heads of Federal agencies, to submit to Congress a report on the impact of a waiver of certain obligations of member nations under the Agreement on Trade-Related Aspects of Intellectual Property Rights on global COVID-19 vaccine access, and for other purposes.
USA117th CongressHR-3694| House
| Updated: 6/4/2021
Earl L. "Buddy" Carter
Republican Representative
Georgia
Ways and Means Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
This bill requires the Department of Health and Human Services (HHS) to submit a report analyzing the impact on global COVID-19 vaccine access of a waiver of certain obligations held by nations who are members of the Agreement on Trade-Related Aspects of Intellectual Property Rights. (India and South Africa previously submitted a petition to suspend all intellectual property rights associated with COVID-19 innovations, such as vaccines.) Based on this report, the U.S. Trade Representative must oppose such elimination or waiver with respect to COVID-19 vaccines if HHS determines that the elimination or waiver will not materially increase global vaccine access or that it will have a negative impact on specified factors relating to access to, manufacture of, and investment in COVID-19 vaccines.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Ways and Means.
Foreign Trade and International Finance
Cardiovascular and respiratory healthCongressional oversightEmergency medical services and trauma careGovernment information and archivesHealth care coverage and accessHealth technology, devices, suppliesImmunology and vaccinationInfectious and parasitic diseasesIntellectual propertyManufacturingProduct development and innovationResearch and developmentTrade agreements and negotiationsWorld health
To direct the Secretary of Health and Human Services, in consultation with the United States Trade Representative and other heads of Federal agencies, to submit to Congress a report on the impact of a waiver of certain obligations of member nations under the Agreement on Trade-Related Aspects of Intellectual Property Rights on global COVID-19 vaccine access, and for other purposes.
USA117th CongressHR-3694| House
| Updated: 6/4/2021
This bill requires the Department of Health and Human Services (HHS) to submit a report analyzing the impact on global COVID-19 vaccine access of a waiver of certain obligations held by nations who are members of the Agreement on Trade-Related Aspects of Intellectual Property Rights. (India and South Africa previously submitted a petition to suspend all intellectual property rights associated with COVID-19 innovations, such as vaccines.) Based on this report, the U.S. Trade Representative must oppose such elimination or waiver with respect to COVID-19 vaccines if HHS determines that the elimination or waiver will not materially increase global vaccine access or that it will have a negative impact on specified factors relating to access to, manufacture of, and investment in COVID-19 vaccines.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Ways and Means.
Earl L. "Buddy" Carter
Republican Representative
Georgia
Ways and Means Committee
Foreign Trade and International Finance
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Cardiovascular and respiratory healthCongressional oversightEmergency medical services and trauma careGovernment information and archivesHealth care coverage and accessHealth technology, devices, suppliesImmunology and vaccinationInfectious and parasitic diseasesIntellectual propertyManufacturingProduct development and innovationResearch and developmentTrade agreements and negotiationsWorld health